National Health Council (NHC) Key Laboratory of Reproduction Regulation, Shanghai Institute of Planned Parenthood Research, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University Shanghai Medical College, Shanghai, China.
Front Immunol. 2022 Dec 2;13:1045532. doi: 10.3389/fimmu.2022.1045532. eCollection 2022.
Recurrent pregnancy loss (RPL) puzzles 1-3% of women of childbearing age worldwide. Immunological factors account for more than 60% of cases of unexplained RPL (URPL); however, the underlying mechanism remains unclear. Here, using single-cell sequencing data and functional experiments with clinical samples, we identified a distinct population of CCR1 decidual macrophages (dMφ) that were preferentially enriched in the decidua from normal early pregnancies but were substantially decreased in patients with URPL. Specific gene signatures endowed CCR1 dMφ with immunosuppressive and migration-regulatory properties, which were attenuated in URPL. Additionally, CCR1 dMφ promoted epithelial-to-mesenchymal transition (EMT) to promote trophoblast migration and invasion by activating the ERK1/2 signaling pathway. Decidual stromal cell (DSC)-derived CCL8 was the key regulator of CCR1 dMφ as CCL8 recruited peripheral CCR1 monocytes, induced a CCR1 dMφ-like phenotype, and reinforced the CCR1 dMφ-exerted modulation of trophoblasts. In patients with URPL, CCL8 expression in DSCs was decreased and trophoblast EMT was defective. Our findings revealed that CCR1 dMφ play an important role in immune tolerance and trophoblast functions at the maternal-fetal interface. Additionally, decreased quantity and dysregulated function of CCR1 dMφ result in URPL. In conclusion, we provide insights into the crosstalk between CCR1 dMφ, trophoblasts, and DSCs at the maternal-fetal interface and macrophage-targeted interventions of URPL.
复发性妊娠丢失 (RPL) 困扰着全球 1-3%的育龄妇女。免疫因素占不明原因 RPL (URPL) 病例的 60%以上;然而,其潜在机制尚不清楚。在这里,我们使用单细胞测序数据和临床样本的功能实验,鉴定了一种独特的 CCR1 蜕膜巨噬细胞 (dMφ) 群体,该群体在正常早期妊娠的蜕膜中优先富集,但在 URPL 患者中明显减少。特定的基因特征赋予 CCR1 dMφ 免疫抑制和迁移调节特性,这些特性在 URPL 中减弱。此外,CCR1 dMφ 通过激活 ERK1/2 信号通路促进上皮间质转化 (EMT),以促进滋养细胞的迁移和侵袭。蜕膜基质细胞 (DSC) 衍生的 CCL8 是 CCR1 dMφ 的关键调节剂,因为 CCL8 募集外周 CCR1 单核细胞,诱导 CCR1 dMφ 样表型,并增强 CCR1 dMφ 对滋养细胞的调节作用。在 URPL 患者中,DSC 中的 CCL8 表达减少,滋养细胞 EMT 缺陷。我们的研究结果表明,CCR1 dMφ 在母胎界面的免疫耐受和滋养细胞功能中发挥重要作用。此外,CCR1 dMφ 的数量减少和功能失调导致 URPL。总之,我们提供了在母胎界面 CCR1 dMφ、滋养细胞和 DSC 之间的串扰以及针对 URPL 的巨噬细胞靶向干预的见解。